BioCryst Pharmaceuticals
BCRX
#4712
Rank
S$2.14 B
Marketcap
$10.34
Share price
1.43%
Change (1 day)
52.51%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Cash on Hand

Cash on Hand as of September 2024 : S$0.43 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has S$0.43 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioCryst Pharmaceuticals - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.51 B-9.69%
2022-12-31S$0.56 B-17.11%
2021-12-31S$0.68 B72.69%
2020-12-31S$0.39 B116.36%
2019-12-31S$0.18 B28.69%
2018-12-31S$0.14 B-6.72%
2017-12-31S$0.15 B93.45%
2016-12-31S$79.09 M8.44%
2015-12-31S$72.93 M-24.15%
2014-12-31S$96.15 M99.43%
2013-12-31S$48.21 M10.75%
2012-12-31S$43.53 M-19.42%
2011-12-31S$54.02 M-22.25%
2010-12-31S$69.48 M-28.23%
2009-12-31S$96.81 M10.03%
2008-12-31S$87.99 M20.61%
2007-12-31S$72.95 M27.01%
2006-12-31S$57.43 M-31.36%
2005-12-31S$83.68 M121.36%
2004-12-31S$37.8 M11.1%
2003-12-31S$34.02 M-19.79%
2002-12-31S$42.42 M-28.36%
2001-12-31S$59.21 M38.69%
2000-12-31S$42.69 M11.01%
1999-12-31S$38.46 M89.4%
1998-12-31S$20.3 M216.96%
1997-12-31S$6.4 M27.16%
1996-12-31S$5.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.07 B 145.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.59 B 263.13%๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.37 M-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.39 B 218.05%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.68 B 739.97%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.00 B 129.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.71 B 1,202.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$92.59 M-78.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.51 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA